Skip to content

Evaluation of the specific bacteriophages to control of E.coli

Evaluation of the specific bacteriophages to control of E.coli in patients with antibiotic-resistant urinary tract infections

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190624043991N14
Enrollment
20
Registered
2021-06-18
Start date
2021-07-07
Completion date
Unknown
Last updated
2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary tract infection. Urinary tract infection, site not specified

Interventions

Intervention 1: Control group: Rinsing the bladder with physiological saline with 20 cc of phosphate buffer salt (PBS), Twice a week for three consecutive months. Intervention 2: Intervention group: R

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with recurrent urinary tract infections more than 3 positive cultures per year with E.coli Age range 20-70 years Consent to participate in the study

Exclusion criteria

Exclusion criteria: pregnant women Patients with allergies

Design outcomes

Primary

MeasureTime frame
Urinary bacteria in patients with antibiotic-resistant urinary tract infections. Timepoint: Twice a week for three consecutive months. Method of measurement: Collect patients' urine samples and check the bacteria count.;Frequent urination in patients with antibiotic-resistant urinary tract infections. Timepoint: Twice a week for three consecutive months. Method of measurement: Collect patients' urine samples and check the bacteria count.;Dysuria in patients with antibiotic-resistant urinary tract infections. Timepoint: Twice a week for three consecutive months. Method of measurement: Collect patients' urine samples and check the bacteria count.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Akram Mirzaei

Tehran University of Medical Sciences

mirzaee.scholar@gmail.com+98 21 6634 8560

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026